Guillaume Wendt
Novartis Germany
Dr. Guillaume Wendt is Evidence Generation Director in the medical department of Novartis Germany. He leads the team responsible for all clinical trials (global and local) and real-world evidence activities running in Germany, as well as the development and implementation of innovative data projects, including AI-driven approaches.
Videos
Unleashing the Power of Health Data
How can Europe turn its vast health data resources into better therapies, faster innovation, and improved patient outcomes? In this DLD Health expert panel discussion, moderator Björn M. Eskofier (LMU Munich), describes the…
Video detailsEvents
DLD Health x BAIOSPHERE
On June 12, 2026, DLD Health and BAIOSPHERE bring together innovators to explore the real-world impact of AI in healthcare and wellbeing…
Event details